市場調查報告書

類風濕性關節炎治療的全球市場:2019年-2025年

Global Rheumatoid Arthritis Market 2019-2025

出版商 Orion Market Research Pvt Ltd 商品編碼 949424
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
類風濕性關節炎治療的全球市場:2019年-2025年 Global Rheumatoid Arthritis Market 2019-2025
出版日期: 2020年05月15日內容資訊: 英文
簡介

全球類風濕性關節炎治療市場,預計到2025年踏實成長。市場擴大的原動力,是糖尿病的盛行率增加和久坐的生活方式擴大等要素。隨著糖尿病的盛行率增加,診斷法和治療方法的市場急速成長,推動類風濕性關節炎治療市場。

本報告提供全球類風濕性關節炎治療市場調查,市場概要,競爭情形,決定市場方向性決策的要素,各治療法,各地區的分析,企業簡介等資訊。

目錄

第1章 報告概要

第2章 市場概要與考察

  • 調查範圍
  • 分析師的考察與市場的最新趨勢
  • 法律規章

第3章 競爭情形

  • 各公司的佔有率分析
  • 主要策略分析
  • 主要企業分析
    • Amgen Inc.
    • Pfizer Inc.
    • AbbVie Inc.
    • Sanofi SA
    • Bristol-Myers Squibb Co.

第4章 市場決策要素

  • 成長促進因素
  • 成長阻礙因素
  • 市場機會

第5章 市場區隔

  • 各治療法市場
    • 醫藥品
    • 手術

第6章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他
  • 其他地區

第7章 企業簡介

  • AbbVie Inc.
  • Allergan PLC
  • Amgen Inc.
  • Anika Therapeutics, Inc.
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Biogen Inc.
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Co.
  • Celltrion Healthcare Co.,Ltd.
  • Eli Lilly and Co.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC
  • Johnson & Johnson Services, Inc.
  • Pfizer Inc.
  • Regeneron Pharmaceuticals Inc.
  • Sanofi SA
  • Swedish Orphan Biovitrum AB (SOBI)
  • Takeda Pharmaceutical Co. Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • UCB S.A.
目錄
Product Code: OMR2021743

Global Rheumatoid Arthritis Market Size, Share & Trends Analysis Report by Treatment (Medications and Surgery) and Forecast 2019-2025

The global rheumatoid arthritis market is projected to witness considerable growth during the forecast period. The major factors contributing to the growth of the market include the increasing prevalence of diabetes and adoption of sedentary lifestyle. With the increasing prevalence of diabetes, measures for diagnosis and treatment are growing at a significant rate, thus, supporting the global rheumatoid arthritis market. The rheumatoid arthritis market is classified on the basis of treatment, which includes medication and surgery. The market for rheumatoid arthritis medications is further segmented into nonsteroidal anti-inflammatory drugs (NSAIDs), disease-modifying anti-rheumatic drugs (DMARDs), biologics, and steroidal medications. Among these medications, DMARDs are one of the major medications prescribed by the rheumatologists for the treatment of rheumatoid arthritis.

Geographically, the global rheumatoid arthritis market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. North America is expected to contribute a significant share in the global market. The growing prevalence of diabetes and fast-moving lifestyle in the US and the presence of major market players, such as Pfizer Inc. and AbbVie Inc., are the factors that are driving the market in this region. Asia-Pacific is expected to project a considerable growth rate in the market during the forecast period. The increasing expenditure of healthcare infrastructure in the emerging economies of the region, such as China and India, is increasing adoption advanced technologies. In addition, the increasing geriatric population in the region have augmented prevalence rate of diabetes, which in turn, is significantly offering growth factor to the rheumatoid arthritis market in the region.

The global rheumatoid arthritis market is influenced by product development and advancements conducted by the market players. The key players of the rheumatoid arthritis market include Amgen Inc., Pfizer Inc., AbbVie Inc., Sanofi SA, Bristol-Myers Squibb Co. Apart from these market players, some other companies that are significantly contributing in the global rheumatoid arthritis market growth includes Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals Inc., GlaxoSmithKline PLC, Teva Pharmaceutical Industries Ltd., UCB S.A., and Biogen Inc. These players are playing a significant role in the growth of the rheumatoid arthritis market by providing various products and adopting several strategies such as merger and acquisition, partnerships and collaboration, technological development, and others.

Research Methodology

The market study of the global rheumatoid arthritis market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary sources include:

  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

1. Global Rheumatoid Arthritis Market Research and Analysis by Treatment

The Report Covers:

  • Comprehensive research methodology of the global rheumatoid arthritis market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global rheumatoid arthritis market.
  • Insights about market determinants which are stimulating the global market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Amgen Inc.
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Pfizer Inc.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. AbbVie Inc.
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Sanofi SA
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Bristol-Myers Squibb Co.
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Rheumatoid Arthritis Market by Treatment
    • 5.1.1. Medications
      • 5.1.1.1. Nonsteroidal anti-inflammatory drugs (NSAIDs)
      • 5.1.1.2. Disease-modifying anti-rheumatic drugs (DMARDs)
      • 5.1.1.3. Biologics
      • 5.1.1.4. Steroidal Medications
    • 5.1.2. Surgery

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. AbbVie Inc.
  • 7.2. Allergan PLC
  • 7.3. Amgen Inc.
  • 7.4. Anika Therapeutics, Inc.
  • 7.5. Astellas Pharma Inc.
  • 7.6. AstraZeneca PLC
  • 7.7. Biogen Inc.
  • 7.8. Boehringer Ingelheim GmbH
  • 7.9. Bristol-Myers Squibb Co.
  • 7.10. Celltrion Healthcare Co.,Ltd.
  • 7.11. Eli Lilly and Co.
  • 7.12. F. Hoffmann-La Roche Ltd.
  • 7.13. GlaxoSmithKline PLC
  • 7.14. Johnson & Johnson Services, Inc.
  • 7.15. Pfizer Inc.
  • 7.16. Regeneron Pharmaceuticals Inc.
  • 7.17. Sanofi SA
  • 7.18. Swedish Orphan Biovitrum AB (SOBI)
  • 7.19. Takeda Pharmaceutical Co. Ltd.
  • 7.20. Teva Pharmaceutical Industries Ltd.
  • 7.21. UCB S.A.

LIST OF TABLES

  • 1. GLOBAL RHEUMATOID ARTHRITIS MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)
  • 2. GLOBAL RHEUMATOID ARTHRITIS MEDICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 3. GLOBAL RHEUMATOID ARTHRITIS SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 4. GLOBAL RHEUMATOID ARTHRITIS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  • 5. NORTH AMERICAN RHEUMATOID ARTHRITIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 6. NORTH AMERICAN RHEUMATOID ARTHRITIS MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)
  • 7. EUROPEAN RHEUMATOID ARTHRITIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 8. EUROPEAN RHEUMATOID ARTHRITIS MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)
  • 9. ASIA-PACIFIC RHEUMATOID ARTHRITIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 10. ASIA-PACIFIC RHEUMATOID ARTHRITIS MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)
  • 11. REST OF THE WORLD RHEUMATOID ARTHRITIS MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL RHEUMATOID ARTHRITIS MARKET SHARE BY TREATMENT, 2018 VS 2025 (%)
  • 2. GLOBAL RHEUMATOID ARTHRITIS MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  • 3. USRHEUMATOID ARTHRITIS MARKET SIZE, 2018-2025 ($ MILLION)
  • 4. CANADA RHEUMATOID ARTHRITIS MARKET SIZE, 2018-2025 ($ MILLION)
  • 5. UKRHEUMATOID ARTHRITIS MARKET SIZE, 2018-2025 ($ MILLION)
  • 6. FRANCE RHEUMATOID ARTHRITIS MARKET SIZE, 2018-2025 ($ MILLION)
  • 7. GERMANY RHEUMATOID ARTHRITIS MARKET SIZE, 2018-2025 ($ MILLION)
  • 8. ITALY RHEUMATOID ARTHRITIS MARKET SIZE, 2018-2025 ($ MILLION)
  • 9. SPAIN RHEUMATOID ARTHRITIS MARKET SIZE, 2018-2025 ($ MILLION)
  • 10. ROE RHEUMATOID ARTHRITIS MARKET SIZE, 2018-2025 ($ MILLION)
  • 11. INDIA RHEUMATOID ARTHRITIS MARKET SIZE, 2018-2025 ($ MILLION)
  • 12. CHINA RHEUMATOID ARTHRITIS MARKET SIZE, 2018-2025 ($ MILLION)
  • 13. JAPAN RHEUMATOID ARTHRITIS MARKET SIZE, 2018-2025 ($ MILLION)
  • 14. REST OF ASIA-PACIFIC RHEUMATOID ARTHRITIS MARKET SIZE, 2018-2025 ($ MILLION)
  • 15. REST OF THE WORLD RHEUMATOID ARTHRITIS MARKET SIZE, 2018-2025 ($ MILLION)